NEWS
Jan 10, 2022
Actimed Therapeutics to Participate at Biotech Showcase 2022
Read more>>>
Dec 14, 2021
Actimed Therapeutics Achieves Major Corporate Milestone – Initiation of first clinical study of new salt of S-pindolol (ACM-001.1)
Read more>>>
Management Team and Board

David Ebsworth

Chairman

Robin Bhattacherjee

Chief Executive Officer

Andrew J. Stewart Coats

Founder and Non-Executive Director

Frank Misselwitz

Chief Medical Officer and Non-executive Director

Stefan Wohlfeil

Non-executive Director

Hugh Jackson

Chief Financial Officer

Pipeline